Skip to Content

Cancers, Volume 16, Issue 6

2024 March-2 - 165 articles

Cover Story: The BCL2 inhibitor venetoclax combined with the hypomethylating agent azacitidine is the new therapeutic standard for elderly or unfit acute myeloid leukemia patients. Despite a 65% composite response rate, overall survival is about 14 months, underlying the need for new therapeutics with improved efficacy and low toxicity. Gene mutations associated with resistance or relapse are TP53, signaling mutations, and the newly described BAX mutations. Venetoclax-based triplet therapies, including IDH and FLT3 inhibitors or menin inhibitors, are under investigation to improve patient outcomes. A better comprehension of genomic and non-genomic evolution upon treatment and the interplay between genomic alterations and apoptosis will allow us to tackle resistance mechanisms in the future. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (165)

  • Article
  • Open Access
4 Citations
2,545 Views
14 Pages

Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma

  • Atsushi Kasamatsu,
  • Ryunosuke Nozaki,
  • Kohei Kawasaki,
  • Tomoaki Saito,
  • Chikashi Minemura,
  • Naohiko Seki,
  • Joel Moss and
  • Katsuhiro Uzawa

21 March 2024

microRNAs (miRs) function in cancer progression as post-transcriptional regulators. We previously reported that endogenous circular RNAs (circRNAs) function as efficient miR sponges and could act as novel gene regulators in oral squamous cell carcino...

  • Article
  • Open Access
5 Citations
3,799 Views
11 Pages

Incidence of Catheter-Associated Bloodstream Infections in Stem Cell Recipients—Should We Be “PICCy”?

  • Sławomir Milczarek,
  • Piotr Kulig,
  • Oliwia Piotrowska,
  • Alina Zuchmańska,
  • Ewa Wilk-Milczarek and
  • Bogusław Machaliński

21 March 2024

The management of patients undergoing HSCT requires a multipurpose central venous catheter. Peripheral catheters (PCs), such as peripherally inserted central catheters (PICCs) and MidLine catheters (MLCs), appear to be adequate vascular catheters to...

  • Article
  • Open Access
7 Citations
3,437 Views
16 Pages

Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment—Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology

  • Luca Giannella,
  • Giovanni Delli Carpini,
  • Jacopo Di Giuseppe,
  • Camilla Grelloni,
  • Giorgio Bogani,
  • Marco Dri,
  • Francesco Sopracordevole,
  • Nicolò Clemente,
  • Giorgio Giorda and
  • Andrea Ciavattini
  • + 19 authors

21 March 2024

Objective: The present study aimed to assess long-term follow-up outcomes in women with in situ/microinvasive adenocarcinoma (AC) of the uterine cervix treated conservatively. Methods: Retrospective multi-institutional study including women with earl...

  • Review
  • Open Access
10 Citations
16,153 Views
23 Pages

Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy

  • Marianna Ciwun,
  • Anna Tankiewicz-Kwedlo and
  • Dariusz Pawlak

21 March 2024

Naltrexone (NTX) is a non-selective antagonist of opioid receptors, primarily used in the therapy of opioid and alcohol dependence. Low-dose naltrexone (LDN) exhibits antagonistic action against the opioid growth factor receptor (OGFr), whose signali...

  • Review
  • Open Access
27 Citations
6,131 Views
30 Pages

Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1

  • Ana Dillen,
  • Indy Bui,
  • Megan Jung,
  • Stephanie Agioti,
  • Apostolos Zaravinos and
  • Benjamin Bonavida

21 March 2024

During the last decade, we have witnessed several milestones in the treatment of various resistant cancers including immunotherapeutic strategies that have proven to be superior to conventional treatment options, such as chemotherapy and radiation. T...

  • Review
  • Open Access
10 Citations
3,047 Views
12 Pages

21 March 2024

Pancreatic cancer is on track to become the second leading cause of cancer-related deaths by 2030, yet there is a lack of accurate diagnostic tests for early detection. Intraductal papillary mucinous neoplasms (IPMNs) are precursors to pancreatic can...

  • Systematic Review
  • Open Access
3 Citations
5,902 Views
17 Pages

Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation

  • Theofanis Vavilis,
  • Maria Louiza Petre,
  • Giannis Vatsellas,
  • Alexandra Ainatzoglou,
  • Eleni Stamoula,
  • Athanasios Sachinidis,
  • Malamatenia Lamprinou,
  • Ioannis Dardalas,
  • Ioannis N. Vamvakaris and
  • Athanasios K. Anagnostopoulos
  • + 2 authors

21 March 2024

Background: Lung cancer is associated with a high incidence of mortality worldwide. Molecular mechanisms governing the disease have been explored by genomic studies; however, several aspects remain elusive. The integration of genomic profiling with i...

  • Article
  • Open Access
2 Citations
3,667 Views
13 Pages

Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities

  • Tae Hoon Lee,
  • Kangpyo Kim,
  • Dongryul Oh,
  • Kyungmi Yang,
  • Han-Sin Jeong,
  • Man Ki Chung and
  • Yong Chan Ahn

21 March 2024

This study aimed to present the treatment patterns and outcomes for adenoid cystic carcinoma (ACC) arising in the nasal cavity and paranasal sinus. Sixty-one sinonasal ACC patients were retrospectively reviewed: 31 (50.8%) underwent surgery followed...

  • Correction
  • Open Access
1,699 Views
5 Pages
  • Article
  • Open Access
2 Citations
2,528 Views
14 Pages

Enhancing Whole-Brain Magnetic Field Homogeneity for 3D-Magnetic Resonance Spectroscopic Imaging with a Novel Unified Coil: A Preliminary Study

  • Archana Vadiraj Malagi,
  • Xinqi Li,
  • Na Zhang,
  • Yucen Liu,
  • Yuheng Huang,
  • Fardad Michael Serry,
  • Ziyang Long,
  • Chia-Chi Yang,
  • Yujie Shan and
  • Hui Han
  • + 5 authors

21 March 2024

The spectral quality of magnetic resonance spectroscopic imaging (MRSI) can be affected by strong magnetic field inhomogeneities, posing a challenge for 3D-MRSI’s widespread clinical use with standard scanner-equipped 2nd-order shim coils. To o...

  • Article
  • Open Access
4 Citations
2,648 Views
15 Pages

Quality of Life, Sarcopenia and Nutritional Status in Patients with Esophagogastric Tumors before and after Neoadjuvant Therapy

  • Lena Schooren,
  • Grace H. Oberhoff,
  • Alexander Koch,
  • Andreas Kroh,
  • Tom F. Ulmer,
  • Florian Vondran,
  • Jan Bednarsch,
  • Ulf P. Neumann,
  • Sophia M. Schmitz and
  • Patrick H. Alizai

21 March 2024

(1) Background: Health-related quality of life (HRQoL) gains importance as novel treatment options for individuals with esophagogastric tumors to improve long-term survival. Impaired HRQoL has been shown to be a predictor of overall survival. Sarcope...

  • Article
  • Open Access
1 Citations
3,544 Views
12 Pages

Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients

  • Hanah Hadice Gull,
  • Antonia Carlotta Von Riegen,
  • Greta Theresa Beckmann,
  • Pikria Ketelauri,
  • Sebastian Walbrodt,
  • Alejandro N. Santos,
  • Christoph Oster,
  • Teresa Schmidt,
  • Martin Glas and
  • Yahya Ahmadipour
  • + 5 authors

21 March 2024

(1) Background: Although the incidence of glioblastoma (GB) has a peak in patients aged 75–84 years, no standard treatment regimen for elderly patients has been established so far. The goal of this study was to analyze the outcome of GB patient...

  • Correction
  • Open Access
1,601 Views
3 Pages

Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447

  • Clemens Zwergel,
  • Rossella Fioravanti,
  • Giulia Stazi,
  • Federica Sarno,
  • Cecilia Battistelli,
  • Annalisa Romanelli,
  • Angela Nebbioso,
  • Eduarda Mendes,
  • Alexandra Paulo and
  • Antonello Mai
  • + 9 authors

21 March 2024

In the original publication [...]

  • Article
  • Open Access
1 Citations
1,899 Views
12 Pages

Preliminary Experience with Virtual Monoenergetic Imaging and Iodine Mapping in the Primary Staging of Endometrial Cancer

  • Stephanie Tina Sauer,
  • Henner Huflage,
  • Sara Aniki Christner,
  • Theresa Sophie Patzer,
  • Matthias Kiesel,
  • Anne Quenzer,
  • Andreas Steven Kunz,
  • Thorsten Alexander Bley and
  • Jan-Peter Grunz

20 March 2024

This study investigated whether virtual monoenergetic images (VMIs) and iodine mapping based on dual-energy CT (DECT) provide advantages in the assessment of endometrial cancer. A dual-source DECT was performed for primary staging of histologically p...

  • Article
  • Open Access
12 Citations
5,470 Views
16 Pages

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study

  • Francesca Romana Mauro,
  • Potito Rosario Scalzulli,
  • Lydia Scarfò,
  • Carla Minoia,
  • Roberta Murru,
  • Paolo Sportoletti,
  • Ferdinando Frigeri,
  • Francesco Albano,
  • Nicola Di Renzo and
  • Stefano Molica
  • + 32 authors

20 March 2024

Real-world data in clinical practice are needed to confirm the efficacy and safety that ibrutinib has demonstrated in clinical trials of patients with chronic lymphocytic leukemia (CLL). We described the real-world persistence rate, patterns of use,...

  • Article
  • Open Access
5 Citations
2,578 Views
18 Pages

T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy

  • Magdalena Absmaier-Kijak,
  • Caterina Iuliano,
  • Susanne Kaesler,
  • Tilo Biedermann,
  • Christian Posch and
  • Knut Brockow

20 March 2024

Immune checkpoint inhibition (ICI) improves outcomes in melanoma patients, but associated T-cell activation frequently leads to immune-related cutaneous adverse events (cutAEs). To dynamically identify T-cell subtypes and immune signatures associated...

  • Article
  • Open Access
8 Citations
4,840 Views
17 Pages

HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches

  • Marta Baptista Freitas,
  • Irene Gullo,
  • Dina Leitão,
  • Lúcia Águas,
  • Carla Oliveira,
  • António Polónia,
  • Joana Gomes,
  • Fátima Carneiro,
  • Celso Albuquerque Reis and
  • Henrique Oliveira Duarte

20 March 2024

Gastric and gastroesophageal junction adenocarcinomas (GA/GEJA) are associated with a poor prognosis, primarily due to late disease diagnosis. Human Epidermal Growth Factor Receptor 2 (HER2) overexpression and programmed death-ligand 1 (PD-L1) expres...

  • Review
  • Open Access
18 Citations
5,963 Views
24 Pages

Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors

  • Ben Ponvilawan,
  • Abdul Wali Khan,
  • Janakiraman Subramanian and
  • Dhruv Bansal

20 March 2024

Immune-related adverse events (irAEs) are the most common complication of immune checkpoint inhibitor (ICI) therapy. With the widespread use of ICIs in patients with solid tumors, up to 40% of the patients develop irAEs within five months of treatmen...

  • Article
  • Open Access
3 Citations
2,140 Views
12 Pages

Early Results of a Screening Program for Skin Cancer in Liver Transplant Recipients: A Cohort Study

  • Delal Akdag,
  • Allan Rasmussen,
  • Susanne Dam Nielsen,
  • Dina Leth Møller,
  • Katrine Togsverd-Bo,
  • Emily Wenande,
  • Merete Haedersdal and
  • Hans-Christian Pommergaard

20 March 2024

(1) Background: Skin cancer is the most common cancer in transplant recipients. Timely and regular screening may reduce advanced disease. The study aimed to determine referral rates to screening, the incidence, and risk factors of skin cancer in a Da...

  • Article
  • Open Access
4 Citations
2,637 Views
18 Pages

Proteomic Profiling of Cerebrospinal Fluid and Its Extracellular Vesicles from Extraventricular Drainage in Pediatric Pilocytic Astrocytoma, towards Precision Oncology

  • Sonia Spinelli,
  • Xhuliana Kajana,
  • Andrea Garbarino,
  • Martina Bartolucci,
  • Andrea Petretto,
  • Marco Pavanello,
  • Enrico Verrina,
  • Giovanni Candiano,
  • Isabella Panfoli and
  • Maurizio Bruschi

20 March 2024

Pediatric pilocytic astrocytoma (PA) is the most common brain tumor in children. Complete resection provides a favorable prognosis, except for unresectable PA forms. There is an incomplete understanding of the molecular and cellular pathogenesis of P...

  • Article
  • Open Access
2,050 Views
16 Pages

Early Gastric Cancers in Central Norway 2001 to 2016—A Population-Based Study

  • Camilla J. Kvamme,
  • Thomas L. Stillingen,
  • Alina D. Sandø,
  • Patricia Mjønes,
  • Erling A. Bringeland and
  • Reidar Fossmark

20 March 2024

Early gastric cancers (EGCs) are confined to the gastric mucosa and submucosa irrespective of lymph node metastases and constitute only a minor proportion of gastric cancer in Western countries. We aimed to characterize EGCs and assess the survival o...

  • Review
  • Open Access
33 Citations
8,992 Views
27 Pages

Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies

  • Marialuisa Piccolo,
  • Maria Grazia Ferraro,
  • Federica Iazzetti,
  • Rita Santamaria and
  • Carlo Irace

20 March 2024

Based on the multifaceted molecular machinery that tightly controls iron cellular homeostasis, this review delves into its paradoxical, potentially dangerous role in biological systems, with a special focus on double-edged sword correlations with can...

  • Article
  • Open Access
2 Citations
2,519 Views
9 Pages

Diagnosis of Metastatic Non-Small Cell Lung Cancer during Hospitalization: Missed Opportunity for Optimal Supportive Care?

  • Shristi Upadhyay Banskota,
  • Jonathan Q. Trinh,
  • Elizabeth Lyden,
  • Conor Houlihan,
  • Samia Asif,
  • Omar Abughanimeh and
  • Benjamin A. Teply

20 March 2024

Purpose: The usual workup for patients newly diagnosed with advanced non-small cell lung cancer (NSCLC) occurs in the ambulatory setting. A subset of patients present with acute care needs and receive the diagnosis while hospitalized. Palliative ther...

  • Article
  • Open Access
8 Citations
3,077 Views
13 Pages

20 March 2024

Purpose: This retrospective cohort study aims to compare the quality of life (QoL) in patients with nasopharyngeal cancer (NPC) treated with intensity-modulated proton therapy (IMPT) versus volumetric modulated arc therapy (VMAT) at different time po...

  • Article
  • Open Access
6 Citations
3,312 Views
9 Pages

In-Hospital Mortality and Associated Factors among Colorectal Cancer Patients in Germany

  • Karel Kostev,
  • Sarah Krieg,
  • Andreas Krieg,
  • Tom Luedde,
  • Sven H. Loosen and
  • Christoph Roderburg

20 March 2024

Background: In the present study, we used the data from 14 hospitals to systematically evaluate the in-hospital mortality of patients with colorectal cancer as well as its influencing factors in Germany. Methods: This multicenter cross-sectional stud...

  • Communication
  • Open Access
3 Citations
2,557 Views
10 Pages

Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)

  • Shybi Mohamedkhan,
  • Sumeet Hindocha,
  • James de Boisanger,
  • Thomas Millard,
  • Liam Welsh,
  • Philip Rich,
  • Andrew D. MacKinnon,
  • Nicholas Williams,
  • Bhupinder Sharma and
  • Anna Minchom
  • + 1 author

20 March 2024

Background and Objective: Brain metastases are common in lung cancer and increasingly treated using targeted radiotherapy techniques such as stereotactic radiosurgery (SRS). Using MRI, post-SRS changes may be difficult to distinguish from progressive...

  • Review
  • Open Access
8 Citations
5,290 Views
18 Pages

Reviewing the Landscape of Cancer Survivorship: Insights from Dr. Lidia Schapira’s Programs and Beyond

  • Viviana Cortiana,
  • Rabab Hunaid Abbas,
  • Soumiya Nadar,
  • Diksha Mahendru,
  • Jade Gambill,
  • Gayathri Pramil Menon,
  • Chandler H. Park and
  • Yan Leyfman

20 March 2024

The constantly escalating population of cancer survivors worldwide has prompted a focused exploration of their unique needs and experiences within the context of healthcare medicine. This review initiates its analysis inspired by Dr. Lidia Schapira&r...

  • Review
  • Open Access
10 Citations
7,988 Views
23 Pages

Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors

  • Paola Roa,
  • Nicole Virginia Bremer,
  • Valentina Foglizzo and
  • Emiliano Cocco

20 March 2024

Since their discovery in 2002, BRAF mutations have been identified as clear drivers of oncogenesis in several cancer types. Currently, their incidence rate is nearly 7% of all solid tumors with BRAF V600E constituting approximately 90% of these diagn...

  • Review
  • Open Access
36 Citations
6,280 Views
17 Pages

Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review

  • Haider Ghazanfar,
  • Nismat Javed,
  • Abeer Qasim,
  • George Sarin Zacharia,
  • Ali Ghazanfar,
  • Abhilasha Jyala,
  • Elona Shehi and
  • Harish Patel

20 March 2024

The prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing globally due to factors such as urbanization, obesity, poor nutrition, sedentary lifestyles, healthcare accessibility, diagnostic advancements, and genetic influences. R...

  • Article
  • Open Access
3 Citations
2,744 Views
15 Pages

Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment

  • Michele Moreau,
  • Lensa S. Keno,
  • Debarghya China,
  • Serena Mao,
  • Shahinur Acter,
  • Gnagna Sy,
  • Hamed Hooshangnejad,
  • Kwok Fan Chow,
  • Erno Sajo and
  • Wilfred Ngwa
  • + 5 authors

20 March 2024

Globally, cervical cancer is the fourth leading cancer among women and is dominant in resource-poor settings in its occurrence and mortality. This study focuses on developing liquid immunogenic fiducial eluter (LIFE) Biomaterial with components that...

  • Review
  • Open Access
20 Citations
7,609 Views
23 Pages

20 March 2024

Circulating tumor cells (CTCs) are cells released from the primary and metastatic tumor and intravasate into the blood or lymphatic vessels, where they are transported to distant sites and act as seeds that initiate cancer metastases or the developme...

  • Correction
  • Open Access
1 Citations
1,366 Views
2 Pages

Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796

  • Giovanna Casili,
  • Sarah Adriana Scuderi,
  • Marika Lanza,
  • Alessia Filippone,
  • Deborah Mannino,
  • Raffaella Giuffrida,
  • Cristina Colarossi,
  • Marzia Mare,
  • Anna Paola Capra and
  • Emanuela Esposito
  • + 5 authors

20 March 2024

In the original publication [...]

  • Article
  • Open Access
7 Citations
4,925 Views
14 Pages

Clinical Workflow of Cone Beam Computer Tomography-Based Daily Online Adaptive Radiotherapy with Offline Magnetic Resonance Guidance: The Modular Adaptive Radiotherapy System (MARS)

  • Ji-Young Kim,
  • Bouchra Tawk,
  • Maximilian Knoll,
  • Philipp Hoegen-Saßmannshausen,
  • Jakob Liermann,
  • Peter E. Huber,
  • Mona Lifferth,
  • Clemens Lang,
  • Peter Häring and
  • Fabian Weykamp
  • + 5 authors

19 March 2024

Purpose: The Ethos (Varian Medical Systems) radiotherapy device combines semi-automated anatomy detection and plan generation for cone beam computer tomography (CBCT)-based daily online adaptive radiotherapy (oART). However, CBCT offers less soft tis...

  • Article
  • Open Access
2 Citations
2,582 Views
19 Pages

Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study

  • Julie Laniel,
  • Serge Sultan,
  • Daniel Sinnett,
  • Caroline Laverdière,
  • Maja Krajinovic,
  • Philippe Robaey,
  • Luc Duong and
  • Sarah Lippé

19 March 2024

Acute lymphoblastic leukemia (ALL) stands as the most prevalent form of pediatric cancer in North America, with a current five-year survival rate of 85%. While more children achieved ALL remission and transition into adulthood, the prevalence of long...

  • Review
  • Open Access
14 Citations
8,197 Views
22 Pages

Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy

  • Angela Hwang,
  • Vedika Mehra,
  • Jyoti Chhetri,
  • Samira Ali,
  • Maxine Tran and
  • Claire Roddie

19 March 2024

Renal cell carcinoma (RCC) affects over 400,000 patients globally each year, and 30% of patients present with metastatic disease. Current standard of care therapy for metastatic RCC involve TKIs and ICIs, including combinatorial strategies, but this...

  • Article
  • Open Access
23 Citations
4,259 Views
11 Pages

Robot-Assisted Radical Prostatectomy by the Hugo Robotic-Assisted Surgery (RAS) System and the da Vinci System: A Comparison between the Two Platforms

  • Hsien-Che Ou,
  • Lucian Marian,
  • Ching-Chia Li,
  • Yung-Shun Juan,
  • Min-Che Tung,
  • Hung-Jen Shih,
  • Chin-Po Chang,
  • Jian-Ting Chen,
  • Che-Hsueh Yang and
  • Yen-Chuan Ou

19 March 2024

Objective: In a previous study, we proved that an experienced urologist is more likely to adapt to the Hugo RAS system. Based on this, we further examine various parameters in this study. Parameters included in this study consisted of console time, f...

  • Review
  • Open Access
84 Citations
18,709 Views
25 Pages

Adaptive Radiotherapy: Next-Generation Radiotherapy

  • Olga Maria Dona Lemus,
  • Minsong Cao,
  • Bin Cai,
  • Michael Cummings and
  • Dandan Zheng

19 March 2024

Radiotherapy, a crucial technique in cancer therapy, has traditionally relied on the premise of largely unchanging patient anatomy during the treatment course and encompassing uncertainties by target margins. This review introduces adaptive radiother...

  • Review
  • Open Access
7 Citations
4,827 Views
17 Pages

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers

  • Ryosuke Sato,
  • Hidekiyo Yamaki,
  • Hiroki Komatsuda,
  • Risa Wakisaka,
  • Takahiro Inoue,
  • Takumi Kumai and
  • Miki Takahara

19 March 2024

Salivary gland cancer (SGC) is rare and comprises over 20 histological subtypes. Recently, clinical experience regarding immunotherapies for SGCs has been accumulating, yet their efficacy remains controversial. Understanding the tumor microenvironmen...

  • Article
  • Open Access
4 Citations
3,309 Views
15 Pages

Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma

  • Emile Gogineni,
  • Blake E. Sells,
  • Khaled Dibs,
  • Sachin R. Jhawar,
  • Catherine T. Haring,
  • Abberly L. Limbach,
  • David J. Konieczkowski,
  • Sung J. Ma,
  • Simeng Zhu and
  • Mauricio E. Gamez
  • + 11 authors

19 March 2024

Background: Salivary duct carcinomas (SDC) are a rare and aggressive subtype of salivary gland neoplasm. They can present with distinct immunoprofiles, such as androgen receptor (AR) and HER-2/Neu-positivity. To date, no consensus exists on how to be...

  • Article
  • Open Access
5 Citations
4,667 Views
28 Pages

19 March 2024

LGG tumors are characterized by a low infiltration of immune cells, requiring therapeutic interventions to boost the immune response. We conducted a study analyzing mRNA expression datasets from the UCSC Xena web platform. To screen for upregulated g...

  • Article
  • Open Access
6 Citations
2,604 Views
10 Pages

19 March 2024

Diagnosing ground-glass opacity (GGO) pulmonary lesions poses challenges. This study evaluates the utility of radial probe endobronchial ultrasound-guided transbronchial lung biopsy (RP-EBUS-TBLB) in diagnosing GGO pulmonary lesions. A total of 1651...

  • Article
  • Open Access
1 Citations
2,818 Views
14 Pages

Stage Shifting by Modifying the Determinants of Breast Cancer Stage at Diagnosis: A Simulation Study

  • Gyanendra Pokharel,
  • Qinggang Wang,
  • Momtafin Khan,
  • Paula J. Robson,
  • Lorraine Shack and
  • Karen A. Kopciuk

19 March 2024

Background: Breast cancer is the most common cancer in Canadian women; nearly 25% of women diagnosed with cancer have breast cancer. The early detection of breast cancer is a major challenge because tumours often grow without causing symptom. The dia...

  • Systematic Review
  • Open Access
7 Citations
3,289 Views
20 Pages

Accuracy of Frozen Section Biopsy in the Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis

  • Stergios Kopatsaris,
  • Aikaterini Apostolopoulou,
  • Ioannis Tsakiridis,
  • Antigoni Tranidou,
  • Fotios Zachomitros,
  • Evangelos Papanikolaou,
  • Alexandros Daponte,
  • Ioannis Kalogiannidis and
  • Themistoklis Dagklis

19 March 2024

The early and accurate diagnosis of endometrial cancer is of paramount importance for the survival of these patients. The aim of this study was to systematically appraise the available data regarding the accuracy of frozen section biopsy in diagnosin...

  • Article
  • Open Access
4 Citations
2,100 Views
12 Pages

Machine Learning Analysis of Post-Operative Tumour Progression in Non-Functioning Pituitary Neuroendocrine Tumours: A Pilot Study

  • Ziad Hussein,
  • Robert W. Slack,
  • Stephanie E. Baldeweg,
  • Evangelos B. Mazomenos and
  • Hani J. Marcus

19 March 2024

Post-operative tumour progression in patients with non-functioning pituitary neuroendocrine tumours is variable. The aim of this study was to use machine learning (ML) models to improve the prediction of post-operative outcomes in patients with NF Pi...

  • Article
  • Open Access
4 Citations
1,863 Views
12 Pages

Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the “Sentinel Envahi et Randomisation du Curage” SERC Trial

  • Camille Nicolas,
  • Claire Petit,
  • Agnès Tallet,
  • Jean-Marie Boher,
  • Leonel Varela Cagetti,
  • Veronique Favrel,
  • Laurence Gonzague Casabianca,
  • Morgan Guenole,
  • Hugues Mailleux and
  • Gilles Houvenaeghel
  • + 11 authors

19 March 2024

Background. An incidental axillary dose of adjuvant radiotherapy using tangential beams is usually given after breast-conserving surgery for breast cancer. The goal of this sub-study was to evaluate this incidental dose in the setting of post-mastect...

  • Systematic Review
  • Open Access
10 Citations
4,809 Views
12 Pages

Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions

  • Rugile Pikturniene,
  • Alvydas Cesas,
  • Sonata Jarmalaite,
  • Arturas Razbadauskas and
  • Vincas Urbonas

18 March 2024

Cutaneous melanoma, an aggressive malignancy, has undergone significant transformation in clinical management with the introduction of immune checkpoint inhibitors (ICIs) and targeted therapies. Current monitoring methods, such as imaging scans, pres...

  • Review
  • Open Access
13 Citations
4,645 Views
17 Pages

Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse

  • Maria Effrosyni Livanou,
  • Vasiliki Nikolaidou,
  • Vasileios Skouras,
  • Oraianthi Fiste and
  • Elias Kotteas

18 March 2024

Immune checkpoint inhibitors (ICIs) are at the forefront of advanced non-small-cell lung cancer (NSCLC) treatment. Still, only 27–46% of patients respond to initial therapy with ICIs, and of those, up to 65% develop resistance within four years...

  • Review
  • Open Access
8 Citations
3,382 Views
12 Pages

CD44 in Bladder Cancer

  • Jason Duex and
  • Dan Theodorescu

18 March 2024

The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a r...

  • Article
  • Open Access
6 Citations
2,334 Views
11 Pages

Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors—The CONKO 020 Investigation

  • Johanna W. Meyer-Knees,
  • Janina Falkenthal,
  • Dominik Geisel,
  • Christopher C. M. Neumann,
  • Georg Hilfenhaus,
  • Lars U. Stephan,
  • Wenzel Schöning,
  • Thomas Malinka,
  • Johann Pratschke and
  • Uwe Pelzer
  • + 1 author

18 March 2024

Background: Pancreatic adenocarcinoma (PDAC) is still a complex, devastating disease. Cachexia symptoms frequently impair patient survival. This accompanying syndrome is commonly diagnosed late, when clinical signs become evident. Early diagnosis usi...

  • Opinion
  • Open Access
11 Citations
3,083 Views
13 Pages

The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts’ Opinion Pictorial Essay

  • Robbert S. Puijk,
  • Madelon Dijkstra,
  • Susan van der Lei,
  • Hannah H. Schulz,
  • Danielle J. W. Vos,
  • Florentine E. F. Timmer,
  • Bart Geboers,
  • Hester J. Scheffer,
  • Jan J. J. de Vries and
  • Martijn R. Meijerink
  • + 5 authors

18 March 2024

With the rapidly evolving field of image-guided tumor ablation, there is an increasing demand and need for tools to optimize treatment success. Known factors affecting the success of (non-)thermal liver ablation procedures are the ability to optimize...

of 4

XFacebookLinkedIn
Cancers - ISSN 2072-6694